No results for ‘’
Natural Capsules Ltd
₹189.39
(0.71%)
Mon, 14 Sept 2026, 02:12 pm
Health Technology
Pharmaceuticals: Other
24.5KNatural Capsules PB Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 5.29 | 4.43 | 4.12 | 1.53 | 4.18 | 4.13 | 3.73 | 2.32 | 3.84 | 6.38 | 16.14 | 77.62 | 58.15 | 21.10 | 23.88 | 9.70 | 23.29 | 19.76 | 51.18 | 293.45 |
| Price to book ratio | 1.12 | 0.82 | 0.64 | 0.31 | 0.77 | 0.69 | 0.61 | 0.40 | 0.41 | 0.79 | 1.12 | 0.91 | 1.19 | 0.73 | 0.37 | 1.08 | 5.21 | 2.96 | 1.40 | 0.82 |
| Price to sales ratio | 0.81 | 0.61 | 0.53 | 0.23 | 0.61 | 0.54 | 0.45 | 0.28 | 0.31 | 0.56 | 1.13 | 0.91 | 1.18 | 0.68 | 0.33 | 0.84 | 2.40 | 2.14 | 1.83 | 1.07 |
| Price to cash flow ratio | 4.96 | 5.48 | 3.89 | 1.72 | 2.58 | 4.17 | 3.77 | 2.37 | 2.86 | 6.50 | 22.30 | 32.99 | 12.29 | 20.17 | 3.03 | 4.79 | 257.46 | 22.58 | 0 | 12.85 |
| Enterprise value | 15.43Cr | 13.42Cr | 11.09Cr | 12.23Cr | 23.4Cr | 26.96Cr | 28.75Cr | 24.53Cr | 23.23Cr | 41.28Cr | 75.37Cr | 51.4Cr | 63.6Cr | 45.42Cr | 26.71Cr | 75.14Cr | 370Cr | 479Cr | 405Cr | 305Cr |
| Enterprise value to EBITDA ratio | 3.41 | 2.83 | 2.01 | 1.66 | 3.01 | 3.02 | 2.98 | 2.67 | 2.54 | 4.52 | 7.73 | 10 | 11.46 | 8.97 | 4.88 | 6.54 | 14.62 | 13.92 | 20.91 | 16.94 |
| Debt to equity ratio | 0.26 | 0.21 | 0.07 | 0.32 | 0.25 | 0.33 | 0.32 | 0.28 | 0.14 | 0.12 | 0.10 | 0.05 | 0 | 0.10 | 0.13 | 0.17 | 0.62 | 0.79 | 0.53 | 0.45 |
| Return on equity % | 0 | 20.06 | 17.62 | 22.34 | 20.05 | 17.86 | 17.43 | 18.63 | 11.48 | 12.59 | 8.44 | 1.14 | 1.96 | 3.50 | 1.54 | 11.74 | 19.18 | 17.89 | 3.40 | 0.28 |
Natural Capsules Ltd Price to Book Ratio
The Natural Capsules Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Natural Capsules Ltd's valuation, profitability, and overall financial performance. Tracking the Natural Capsules Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Natural Capsules Ltd (NSE: NATCAPSUQ, BSE: 524654) is currently trading at ₹189.39, with a market capitalization of ₹196.25Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Natural Capsules Ltd Price to Book Ratio is essential for fundamental analysis.
Natural Capsules Ltd Price to Book Ratio Current Value
The current Natural Capsules Ltd Price to Book Ratio stands at 0.82.
The Natural Capsules Ltd Price to Book Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Natural Capsules Ltd Price to Book Ratio Historical Trend
The Natural Capsules Ltd Price to Book Ratio has shown the following historical trend:
- 2024: 0.82
- 2023: 1.40
- 2022: 2.96
- 2021: 5.21
- 2020: 1.08
The decline in Natural Capsules Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.
What Natural Capsules Ltd Price to Book Ratio Indicates for Investors
The Natural Capsules Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/B ratio shows how the market values company assets relative to book value.
Natural Capsules Ltd Price to Book Ratio Analysis Summary
The Natural Capsules Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Natural Capsules Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Natural Capsules Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.